Goldman Sachs, Merrill Lynch Accused Under RICO

James West
|

By James West
MidasLetter.com
December 19, 2010

Perrenial warrior against naked short selling and Overstock.com CEO Patrick Byrne has amended a previously filed lawsuit against Goldma Sachs and Merrill Lynch to include charges under New Jersey RICO laws.

The original lawsuit, filed in the California superior court in San Francisco, alleged that Goldman Sachs Group Inc and Bank of America’s Merrill Lynch unit engaged in a “massive, illegal stock market manipulation scheme” that involved so-called naked short-selling.

In naked short selling, short sales are executed but never delivered, thereby causing the company’s share price to fall.

“Merrill, Goldman and certain of their market maker clients agreed to and created a scheme to effect the naked short selling in Overstock securities that is the subject of this action, in order to perpetuate short selling and drive down the price of Overstock, to their mutual profit,” alleges the motion, which was filed on Wednesday.

Jonathan Johnson, President of Overstock.com, stated, “Recently discovered revelations of concerted action among certain market makers and these two brokerages necessitate that we amend our complaint to include additional claims. We expect that this conduct of Goldman Sachs and Merrill Lynch is fully actionable under anti-racketeering laws.”

James West

James West

Editor and Publisher

James West founded Midas Letter in 2008 and has since been covering the best of Canadian and US small cap companies. He covers global economics, monetary policy, geopolitical evolution, political corruption, commodities, cannabis and cryptocurrencies. As an active market participant, James is not a journalist and is invariably discussing markets...
More Info...

[email protected] | |

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.